The efficacy and safety of intravenous chlorpromazine treatment for sleep disturbance in incurable cancer patients with difficulty receiving oral administration.
Not Applicable
- Conditions
- sleep disturbance in incurable cancer patients
- Registration Number
- JPRN-UMIN000043869
- Lead Sponsor
- Kansai Medical University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 52
Inclusion Criteria
Not provided
Exclusion Criteria
mental disorders such as dementia, which would create difficulties in completing St. Marys Hospital sleep questionnaire.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The efficacy rate of the St. Marys Hospital sleep questionnaire on sleep quality seven days after the intravenous chlorpromazine dose.
- Secondary Outcome Measures
Name Time Method